BioCentury
ARTICLE | Company News

Evotec OAI AG, Guilford deal

May 17, 2004 7:00 AM UTC

The companies partnered to develop small molecules against GLFD targets. EVT will develop assays and perform ultra-high throughput screening to identify compounds. EVT also will characterize selected ...